Novel transcript, antisense to apolipoprotein A4

This entity is a long non-coding RNA (lncRNA) generated from the strand antisense to the APOA4 gene (apolipoprotein A4), as annotated in genomic databases[1]. Antisense transcripts like this are widespread in human and other eukaryotic genomes, and are increasingly recognized for their regulatory roles. General mechanisms known for antisense lncRNAs include modulating the expression, stability, and processing of their sense (protein-coding) gene partners via RNA–RNA interactions or by altering chromatin states[2][3]. At present, there is no published evidence that this particular transcript (ENSG00000285513) acts as a therapeutic target, encodes a protein, interacts with any drugs, or has validated utility as a biomarker. Its main relevance is as a non-coding RNA with potential regulatory function over the APOA4 gene, possibly through effects typical of antisense lncRNAs such as influencing transcription rates, transcript processing, or epigenetic chromatin configuration[2][3][4]. No established associations with disease, druggability, or pathogenic mechanisms have been described in scientific literature for this transcript.

Other names

Novel transcript, antisense to APOA4ENSG00000285513